Lv4
588 积分 2021-05-14 加入
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
3天前
已完结
FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review
20天前
已完结
FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review
20天前
已关闭
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
30天前
已完结
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
30天前
已完结
Low-Grade Endometrial Stromal Sarcoma - a Review
1个月前
已完结
CDK4/6 inhibitors in breast cancer: spotting the difference
1个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
1个月前
已完结
Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
1个月前
已完结
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group
1个月前
已完结
皖公网安备34019202002308
